Detalles de la búsqueda
1.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol
; 25(5): e193-e204, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697165
2.
Long term update on toxicity and survival of a phase II trial of linac-based stereotactic body radiation therapy for low-intermediate risk prostate cancer.
Prostate
; 84(4): 368-375, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38112222
3.
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial.
Cancer
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581694
4.
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study.
Prostate
; 83(12): 1201-1206, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37290915
5.
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers.
Support Care Cancer
; 32(1): 38, 2023 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38110572
6.
Oncological outcomes of cervical esophageal cancer treated primarily with surgery: a systematic review and meta-analysis.
Eur Arch Otorhinolaryngol
; 280(1): 373-390, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35969248
7.
Radiomics-based prognosis classification for high-risk prostate cancer treated with radiotherapy.
Strahlenther Onkol
; 198(8): 710-718, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35059760
8.
Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy.
Acta Oncol
; 61(5): 553-559, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35200085
9.
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group.
Oral Dis
; 28(2): 345-351, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33320410
10.
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors.
Eur Neurol
; 85(6): 453-459, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35772386
11.
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions.
Eur Arch Otorhinolaryngol
; 279(1): 527-531, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34213607
12.
Stereotactic radiotherapy for liver oligometastases.
Rep Pract Oncol Radiother
; 27(1): 32-39, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35402041
13.
Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity.
Strahlenther Onkol
; 197(2): 133-140, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33006025
14.
Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy.
Strahlenther Onkol
; 197(5): 396-404, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32970163
15.
Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario.
Int J Clin Oncol
; 26(10): 1777-1783, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34273014
16.
Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment.
Rep Pract Oncol Radiother
; 26(1): 101-110, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34046220
17.
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis.
Strahlenther Onkol
; 196(3): 213-221, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31559480
18.
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Strahlenther Onkol
; 196(10): 922-931, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31722061
19.
Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer : Long-term results and factors predictive for outcome and toxicity.
Strahlenther Onkol
; 196(7): 608-616, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303782
20.
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.
Strahlenther Onkol
; 196(4): 325-333, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605163